• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Contemporary outcomes of long-term anticoagulation in COVID-19 patients: a regression matched sensitivity analysis of the national inpatient sample
CONCLUSIONS: Compared to COVID-19 patients not on long-term anticoagulation, we observed lower in-hospital mortality, stroke and acute myocardial infarction in COVID-19 patients on long-term anticoagulation. Prospective studies are needed for optimal anticoagulation strategies in hospitalized patients.PMID:37409406 | DOI:10.1080/14779072.2023.2234282
Source: Expert Review of Cardiovascular Therapy - July 6, 2023 Category: Cardiology Authors: Amro Taha Irisha Badu Harigopal Sandhyavenu Varun Victor Sanchit Duhan Lalitsiri Atti Hasham Masood Qureshi Thatiana Schulze Goni Bijeta Keisham Vasantha Sandhya Venu Harshith Thyagaturu Karthik Gonuguntla Waqas Ullah Himanshu Deshwal Sudarshan Balla Source Type: research

The SARS-CoV-2 responsible for phlegmasia cerulea dolens: a case report
CONCLUSION: Although the severe acute respiratory syndrome coronavirus 2 remains a thrombogenic pathology, systematic anticoagulation is the subject of hypothesis. Hence the importance of regular monitoring of markers of vascular thrombosis.PMID:37008170 | PMC:PMC10060091 | DOI:10.1097/MS9.0000000000000152
Source: Annals of Medicine - April 3, 2023 Category: Internal Medicine Authors: Youssef Banana Husam Bashir Sara Boukabous Intissar Haddiya Yassamine Bentata Abdellah Rezziki Adnane Benzirar Omar El Mahi Source Type: research

Cardiovascular Effects of COVID-19
The COVID-19 pandemic has had a dramatic impact on the care of patients with cardiovascular disease throughout the world. COVID-19 has a myriad of direct effects on the myocardium, vasculature, and coagulation cascade, related to the proinflammatory and prothrombotic effects of the virus, leading to an increased risk of myocardial infarction, stroke, deep venous thrombosis, and pulmonary emboli within the first 2 to 4 weeks of contracting the disease (Fig.  1).1–4
Source: Heart Failure Clinics - March 1, 2023 Category: Cardiology Authors: Timothy D. Henry, Santiago Garcia, Eduardo Bossone Tags: Preface Source Type: research

Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series
This study provides further evidence that COVID-19 is a multisystem disease involving neurologic, cardiac and thrombotic dysfunction, without evidence of hepatic dysfunction. Patients have persistent organ dysfunction after hospital discharge, underscoring the need for research on long-term outcomes of COVID-19 survivors.PMID:35853662 | DOI:10.9778/cmajo.20210151
Source: cmaj - July 19, 2022 Category: General Medicine Authors: Kimia Honarmand Kyle Fiorini Debarati Chakraborty Daniel Gillett Karishma Desai Claudio Martin Karen J Bosma Marat Slessarev Ian M Ball Tina Mele Danielle LeBlanc Sameer Elsayed Alejandro Lazo-Langner Mike J Nicholson Robert Arntfield John Basmaji Source Type: research

Pages: 1  2  3  4